Growth Metrics

Avanos Medical (AVNS) Long-Term Deferred Tax (2016 - 2024)

Historic Long-Term Deferred Tax for Avanos Medical (AVNS) over the last 11 years, with Q3 2024 value amounting to $6.6 million.

  • Avanos Medical's Long-Term Deferred Tax rose 5348.84% to $6.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.6 million, marking a year-over-year increase of 5348.84%. This contributed to the annual value of $6.5 million for FY2023, which is 4130.43% up from last year.
  • Latest data reveals that Avanos Medical reported Long-Term Deferred Tax of $6.6 million as of Q3 2024, which was up 5348.84% from $6.3 million recorded in Q2 2024.
  • Avanos Medical's Long-Term Deferred Tax's 5-year high stood at $61.9 million during Q2 2021, with a 5-year trough of $4.3 million in Q3 2023.
  • Over the past 5 years, Avanos Medical's median Long-Term Deferred Tax value was $10.0 million (recorded in 2020), while the average stood at $12.4 million.
  • As far as peak fluctuations go, Avanos Medical's Long-Term Deferred Tax skyrocketed by 34214.29% in 2021, and later tumbled by 8206.79% in 2022.
  • Quarter analysis of 5 years shows Avanos Medical's Long-Term Deferred Tax stood at $10.0 million in 2020, then changed by 0.0% to $10.0 million in 2021, then plummeted by 54.0% to $4.6 million in 2022, then surged by 41.3% to $6.5 million in 2023, then increased by 1.54% to $6.6 million in 2024.
  • Its last three reported values are $6.6 million in Q3 2024, $6.3 million for Q2 2024, and $6.3 million during Q1 2024.